Beijing, China

Yan Mi


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Yan Mi - Innovator in Drug Synthesis

Introduction

Yan Mi is a prominent inventor based in Beijing, China. She has made significant contributions to the field of drug synthesis, particularly through her innovative methods for preparing pharmaceuticals. Her work is characterized by a focus on improving the quality and yield of drug products.

Latest Patents

Yan Mi holds a patent for a method of preparing lornoxicam. This method involves using 6-chloro-4-hydroxy-2-methyl-2-H-thieno[2,3-e]-1,2-thiazine methyl carboxylate-1,1-dioxide and 2-aminopyridine as raw materials, with xylene as a solvent. The process includes mixing the raw materials and solvent, adding a stabilizer, and subjecting the mixture to ammonolysis. The resulting reactant is cooled, and the solvent is removed through vacuum concentration. An organic solvent is then added, and the mixture is filtered to obtain crude lornoxicam, which is subsequently refined. The use of p-toluenesulfonic acid as a stabilizer is a key aspect of this method, as it reduces the reaction temperature and enhances the overall reaction efficiency.

Career Highlights

Yan Mi is currently employed at Beijing Jincheng Taier Pharmaceutical Co., Ltd. Her work at this company has allowed her to focus on drug synthesis and contribute to the development of new pharmaceutical methods. With a patent portfolio that includes 1 patent, she has established herself as a valuable asset in the pharmaceutical industry.

Collaborations

Yan Mi collaborates with talented colleagues, including Zhen Liu and Dongye Xing. These partnerships enhance her research and development efforts, fostering innovation in drug synthesis.

Conclusion

Yan Mi is a dedicated inventor whose work in drug synthesis has the potential to impact the pharmaceutical industry significantly. Her innovative methods and collaborations with skilled professionals highlight her commitment to advancing drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…